CClinicalTrials.gg
CompletedNCT02907151EDUCONSULTUpdated May 7, 2018

Evaluation of the Contribution of a Pre-consultation Questionnaire on the Therapeutic Education

An observational study in Under Oral Anticoagulation Patients, sponsored by University Hospital, Montpellier. Completed at 1 site in France. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2018-05-07.

Sponsored by University Hospital, Montpellier · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
160
Ages
18 Years to 100 Years
Sex
All
01

Study summary

To assess the value of a dedicated knowledge questionnaire, filled by the patient prior consultation. Indeed, it could allow to target specific shortcomings of patients first, and help the cardiologist to prioritize the other therapeutic education, targeting specifically the information provided.

Read the detailed description

The main objective is to study the impact of a pre-consultation questionnaire on the knowledge gained by the patient on anticoagulant treatment at the exit of cardiology consultation.

The assumption is that this questionnaire would help educate patients about their shortcomings and educate cardiologists lack of knowledge of his patient.

The secondary objectives are :

  • Target specific areas in which patients have the greatest lack of information
  • Assess the impact of educational level on information
  • Assess the impact of age on information
  • Evaluate the satisfaction of the information delivered
  • Assess patient anxiety vis-à-vis their treatment
  • Evaluate the failure rate of the questionnaire to know the number of patients refusing to participate in the study
02

Conditions studied

  • Under Oral Anticoagulation Patients
03

In context

Lead sponsor

University Hospital, Montpellier is the lead sponsor of 1,244 studies on the registry; 225 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All patients scheduled for cardiac consultation treated with oral anticoagulation

Inclusion criteria

  • Patient monitoring Cardiology Consultation at University Hospital of Montpellier, whatever the reason
  • Patients on oral anticoagulant therapy (warfarin or AOD) for over a month.

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive disorders, making it impossible to understand the patient on therapeutic education.
  • Disorders of the important vision.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
160 participants (actual)
Patient registry
No

Groups and cohorts

  • pre-consultation survey group

    The group completing a pre consultation survey filled the same questionnaire in post consultation but the doctor will see the result in the consultation.

    Other: Survey

  • Group absence of pre-consultation survey

    This group will be a control group to see if there is a difference between completing a pre-consultation survey before or not.

Interventions

  • OtherSurvey

    Complete a survey prior to the consultation and a questionnaire after

06

What researchers measure

Primary outcomes

  1. number of correct answers

    score (number of correct answers) to the survey

    Time frame: 3 months

Secondary outcomes

  1. Score information

    Score information for the different areas of the survey

    Time frame: 3 months

  2. Score on the provision of additional information

    Score on the provision of additional information in the consultation.

    Time frame: 3 months

  3. anxiety score

    anxiety score by a self-evaluation of the patient.

    Time frame: 3 months

  4. Score information based on subgroups

    Score information based on subgroups: * level of education * Age * Sex

    Time frame: 3 months

07

Study locations

1 site
  • Leclercq
    Montpellier, 34295, France
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02907151
Lead sponsor
University Hospital, Montpellier
Responsible party
Sponsor
First posted
Sep 20, 2016
Start date
Sep 2016
Primary completion
Jan 2017
Completion
Mar 2017
Last update
May 7, 2018

Study contacts

Florence Leclercq, MD PHD
study director · University Hospital, Montpellier

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion